Global Medical REIT (NASDAQ:GMRE) Given News Impact Score of 0.17

Media coverage about Global Medical REIT (NASDAQ:GMRE) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Global Medical REIT earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.1825871900876 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Global Medical REIT (NASDAQ GMRE) opened at 9.14 on Friday. The firm’s 50-day moving average is $9.09 and its 200 day moving average is $9.05. Global Medical REIT has a 12 month low of $6.73 and a 12 month high of $11.09.

Global Medical REIT (NASDAQ:GMRE) last issued its quarterly earnings data on Thursday, August 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.13 by $0.17. The company had revenue of $7.42 million for the quarter, compared to the consensus estimate of $6.16 million. Global Medical REIT had a negative net margin of 54.55% and a negative return on equity of 6.70%. On average, equities analysts anticipate that Global Medical REIT will post ($0.11) EPS for the current year.

A number of research analysts recently commented on GMRE shares. Zacks Investment Research raised shares of Global Medical REIT from a “sell” rating to a “buy” rating and set a $11.00 target price on the stock in a research report on Wednesday, May 10th. FBR & Co reaffirmed an “outperform” rating and issued a $10.00 target price on shares of Global Medical REIT in a research report on Tuesday, July 11th. Finally, TheStreet raised shares of Global Medical REIT from a “d” rating to a “c-” rating in a research report on Monday, July 10th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $10.67.

COPYRIGHT VIOLATION WARNING: “Global Medical REIT (NASDAQ:GMRE) Given News Impact Score of 0.17” was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://www.com-unik.info/2017/08/19/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-global-medical-reit-nasdaqgmre-share-price-updated-updated-updated.html.

In other Global Medical REIT news, Chairman Jeffrey Busch bought 11,100 shares of the stock in a transaction dated Friday, June 30th. The stock was bought at an average cost of $9.00 per share, for a total transaction of $99,900.00. Following the completion of the purchase, the chairman now owns 20,110 shares in the company, valued at approximately $180,990. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

What are top analysts saying about Global Medical REIT Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Global Medical REIT Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit